secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0000899923-23-000041
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics shareholders approve equity plan increase and charter amendments at 2023 annual meeting
--------------------------------------------------------------------------------

- Elected Paul M. Bisaro, Rashmi Kumar, and Lee N. Newcomer as directors for terms expiring 2026.
- Approved amendment to 2017 Equity Plan to add 4.8 million shares for future grants.
- Approved certificate amendments: federal forum selection clause and officer exculpation.
- Ratified Ernst & Young as independent auditor for fiscal 2023.
- Advisory vote approved executive compensation and favored annual frequency for future votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992323000041/0000899923-23-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992323000041/mygn-20230601.htm
  HTML page:      https://secwatch.observer/filing/0000899923-23-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer